Patents by Inventor Robert A. Sutherland

Robert A. Sutherland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230191131
    Abstract: A system may include a therapy device configured to deliver a therapy to a patient, a feature detector, and a feature selection controller. The therapy device may include sensing circuitry configured to sense a biological signal from the patient, and a closed-loop controller operably connected to the therapy device and the sensing circuitry. The controller may be configured to implement a feedback control algorithm to control the delivered therapy based on the sensed signal by controlling at least one therapy parameter. The feature detector may be configured to detect a plurality of available features of the biological signal. The feature selection controller may be configured to implement a feature selection algorithm to determine closed-loop sensed feature(s) from the plurality of available features. The feedback control algorithm may be configured to use the at least one closed-loop sensed feature to control the therapy parameter(s).
    Type: Application
    Filed: December 20, 2022
    Publication date: June 22, 2023
    Inventors: Adarsh Jayakumar, Robert Sutherland
  • Patent number: 10781116
    Abstract: Devices, systems and methods for applying electromagnetic fields to liquids, such as water, to treat unwanted material in the liquid are disclosed. Such devices, systems and methods may include a cylindrically shaped, water-immersible probe configured to generate electromagnetic fields that are effective to treat unwanted materials, such as scale, and microbes in the water.
    Type: Grant
    Filed: February 17, 2015
    Date of Patent: September 22, 2020
    Assignee: Reverse Ionizer Systems, LLC
    Inventors: Patrick J. Hughes, Desmond A. Fraser, Hossein Ghaffari Nik, Richard B. McMurray, Robert A. Sutherland
  • Patent number: 9856157
    Abstract: Electromagnetic water treatment devices for applying electromagnetic fields to liquids, such as water are disclosed. The water treatment devices may include a water-immersible probe configured to generate electromagnetic output fields effective to remove scale, prevent the growth of scale and/or eliminate microbes in a water supply system. Systems and methods for treating water using the disclosed devices are also provided.
    Type: Grant
    Filed: January 31, 2014
    Date of Patent: January 2, 2018
    Inventors: Patrick J. Hughes, Desmond A. Fraser, Hossein Nik Ghaffari, Robert A. Sutherland
  • Publication number: 20150239757
    Abstract: Devices, systems and methods for applying electromagnetic fields to liquids, such as water, to treat unwanted material in the liquid are disclosed. Such devices, systems and methods may include a cylindrically shaped, water-immersible probe configured to generate electromagnetic fields that are effective to treat unwanted materials, such as scale, and microbes in the water.
    Type: Application
    Filed: February 17, 2015
    Publication date: August 27, 2015
    Applicant: Reverse Ionizer, Inc.
    Inventors: Patrick J Hughes, Desmond A. Fraser, Hossein Ghaffari Nik, Richard B. McMurray, Robert A. Sutherland
  • Publication number: 20140216936
    Abstract: Electromagnetic water treatment devices for applying electromagnetic fields to liquids, such as water are disclosed. The water treatment devices may include a water-immersible probe configured to generate electromagnetic output fields effective to remove scale, prevent the growth of scale and/or eliminate microbes in a water supply system. Systems and methods for treating water using the disclosed devices are also provided.
    Type: Application
    Filed: January 31, 2014
    Publication date: August 7, 2014
    Applicant: Reverse Ionizer, Inc.
    Inventors: Patrick J. Hughes, Desmond A. Fraser, Hossein Nik Ghaffari, Robert A. Sutherland
  • Patent number: 8535712
    Abstract: The present invention relates to a radiation sensitive liposome, and the use of this liposome as carrier for therapeutic and diagnostic agent(s). In particular, the invention encompasses a liposomal delivery system, comprising a stable liposome-forming lipid and a polymerizable colipid, a fraction of which polymerizable colipid polymerizes upon exposure to ionizing radiation, thereby destabilizing the liposomal membrane. Destabilization of liposomes allows for leakage of liposomal contents. The present invention further contemplates methods of diagnosing and treating conditions and diseases that are responsive to liposome-encapsulated or associated agents.
    Type: Grant
    Filed: September 10, 2012
    Date of Patent: September 17, 2013
    Assignees: Varian Medical Systems, Inc., Arizona Board of Regents on Behalf of the University of Arizona
    Inventors: David F. O'Brien, Kathy A. McGovern, Bruce Bondurant, Robert Sutherland
  • Publication number: 20130224730
    Abstract: A method of solid phase selection of peptide ligands for target proteins is presented. 15-20mers or greater are addressed in a microarray, and the target protein and optional competitor bound thereto and binding compared. A specific signal for the target protein indicates that a peptide has strong affinity for the target. Ligands can be coupled to solid supports and used for affinity purification of the target proteins as well as detection and modulation of target proteins. Specific peptide ligands for immuno-purifying norovirus.
    Type: Application
    Filed: November 16, 2010
    Publication date: August 29, 2013
    Applicant: ARIZONA BOARD OF REGENTS ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Stephen A. Johnston, Christopher Diehnelt, Paul Belcher, Charles J. Arntzen, Robert Sutherland
  • Publication number: 20130202577
    Abstract: The invention relates to the finding that T cell protein tyrosine phosphatase (TCPTP) has a tumour suppressor function. In one particular application, the invention provides a method of diagnosis and/or prognosis of cancer in a subject involving the assessment, in a suitable body sample, of any lack or reduction of TCPTP protein and/or Ptpn2 gene expression. The invention also provides a method of treating or preventing cancer in a subject involving administering to a subject an agent for modulating the activity of TCPTP.
    Type: Application
    Filed: February 3, 2011
    Publication date: August 8, 2013
    Applicant: MONASH UNIVERSITY
    Inventors: Tony Tiganis, Benjamin James Shields, Catriona Ann McLean, Robert Sutherland
  • Publication number: 20130053618
    Abstract: The present invention relates to a radiation sensitive liposome, and the use of this liposome as carrier for therapeutic and diagnostic agent(s). In particular, the invention encompasses a liposomal delivery system, comprising a stable liposome-forming lipid and a polymerizable colipid, a fraction of which polymerizable colipid polymerizes upon exposure to ionizing radiation, thereby destabilizing the liposomal membrane. Destabilization of liposomes allows for leakage of liposomal contents. The present invention further contemplates methods of diagnosing and treating conditions and diseases that are responsive to liposome-encapsulated or associated agents.
    Type: Application
    Filed: September 10, 2012
    Publication date: February 28, 2013
    Applicant: Varian Medical Systems, Inc.
    Inventors: David F. O'Brien, Kathy A. McGovern, Bruce Bondurant, Robert Sutherland
  • Publication number: 20110217236
    Abstract: The present invention relates to a radiation sensitive liposome, and the use of this liposome as carrier for therapeutic and diagnostic agent(s). In particular, the invention encompasses a liposomal delivery system, comprising a stable liposome-forming lipid and a polymerizable colipid, a fraction of which polymerizable colipid polymerizes upon exposure to ionizing, radiation, thereby destabilizing the liposomal membrane. Destabilization of liposomes allows for leakage of liposomal contents. The present invention further contemplates methods of diagnosing and treating conditions and diseases that are responsive to liposome-encapsulated or associated agents.
    Type: Application
    Filed: October 11, 2010
    Publication date: September 8, 2011
    Applicant: Varian Medical Systems, Inc.
    Inventors: David F. O'Brien, Kathy A. McGovern, Bruce Bondurant, Robert Sutherland
  • Patent number: 7700316
    Abstract: The invention is a CD109 nucleic acid molecule and its corresponding polypeptide. The invention also includes biologically functional equivalent nucleic acid molecules and polypeptides. The invention also relates to methods of using these nucleic acid sequences and polypeptides in medical diagnosis and treatment and in drug screening.
    Type: Grant
    Filed: March 7, 2002
    Date of Patent: April 20, 2010
    Inventors: Andre Schuh, D. Robert Sutherland
  • Patent number: 7660384
    Abstract: A method of imaging a patient's uncompressed region of interest using X-ray cone beam computed tomography or cone beam digital tomography comprises the step of introducing an effective amount of a contrast agent to the uncompressed region of interest. A system for imaging a patient's uncompressed region of interest using cone beam computed tomography (CBCT) or cone beam digital tomography (CBDT) comprises an X-ray source transmitting an X-ray to the uncompressed region of interest, an image acquisition system acquiring a plurality of two-dimensional projection images data for a CBCT or CBDT data set with at least one of the projection images acquired in 35 milliseconds or less, and a processor generating a three-dimensional computed tomography image data set resolving voxels with dimensions of 0.4 mm or less in at least two orthogonal directions.
    Type: Grant
    Filed: May 23, 2008
    Date of Patent: February 9, 2010
    Assignee: Varian Medical Systems, Inc.
    Inventors: Larry Partain, Stavros Prionas, Edward Seppi, Robert Sutherland, David Humber, Hassan Mostafavi, Felix Fernando, John Boone
  • Publication number: 20090233286
    Abstract: Disclosed herein are methods of diagnosing pancreatic cancer in a subject. Also provided are methods of monitoring the efficacy of a therapeutic treatment of pancreatic cancer as well as methods of determining the likelihood that a subject having pancreatic cancer will survive, and methods of determining the suitability of a subject having pancreatic cancer for surgical resection therapy.
    Type: Application
    Filed: October 22, 2008
    Publication date: September 17, 2009
    Inventors: Davendra Segara, Andrew Biankin, Robert Sutherland, Susan Henshall
  • Publication number: 20080226018
    Abstract: A method of imaging a patient's uncompressed region of interest using X-ray cone beam computed tomography or cone beam digital tomography comprises the step of introducing an effective amount of a contrast agent to the uncompressed region of interest. A system for imaging a patient's uncompressed region of interest using cone beam computed tomography (CBCT) or cone beam digital tomography (CBDT) comprises an X-ray source transmitting an X-ray to the uncompressed region of interest, an image acquisition system acquiring a plurality of two-dimensional projection images data for a CBCT or CBDT data set with at least one of the projection images acquired in 35 milliseconds or less, and a processor generating a three-dimensional computed tomography image data set resolving voxels with dimensions of 0.4 mm or less in at least two orthogonal directions.
    Type: Application
    Filed: May 23, 2008
    Publication date: September 18, 2008
    Applicant: Varian Medical Systems Technologies, Inc.
    Inventors: Larry D. Partain, Stavros Prionas, Edward Seppi, Robert Sutherland, David Humber, Hassan Mostafavi, Felix Fernando, John Boone
  • Patent number: 7394889
    Abstract: A method of imaging a patient's uncompressed region of interest using X-ray cone beam computed tomography or cone beam digital tomography comprises the step of introducing an effective amount of a contrast agent to the uncompressed region of interest. A system for imaging a patient's uncompressed region of interest using cone beam computed tomography (CBCT) or cone beam digital tomography (CBDT) comprises an X-ray source transmitting an X-ray to the uncompressed region of interest, an image acquisition system acquiring a plurality of two-dimensional projection images data for a CBCT or CBDT data set with at least one of the projection images acquired in 35 milliseconds or less, and a processor generating a three-dimensional computed tomography image data set resolving voxels with dimensions of 0.4 mm or less in at least two orthogonal directions.
    Type: Grant
    Filed: May 18, 2006
    Date of Patent: July 1, 2008
    Assignee: Varian Medical Systems Technologies, Inc.
    Inventors: Larry D. Partain, Stavros Prionas, Edward Seppi, Robert Sutherland, David Humber, Hassan Mostafavi, Felix Fernando, John Boone
  • Publication number: 20080110968
    Abstract: A carton with a new dispenser that can be opened by a pull tab with this dispenser flap being placed in a corner of the top panel of the carton so that it is adjacent to the tops of the small necks of the bottles for easy opening and removal or for opening and reclosing. The dispenser flap is held in position by resistant tear lines but can be easily removed by an attached pull tab that is loosely connected to the top panel.
    Type: Application
    Filed: January 8, 2008
    Publication date: May 15, 2008
    Inventors: Robert Sutherland, Raymond Spivey, Glen Harrelson
  • Publication number: 20070295796
    Abstract: A carton can be placed in a dispensing configuration by separating the carton into dispenser sections. The dispenser sections may be connected by a hinge that allows the sections to stand side-by-side.
    Type: Application
    Filed: June 25, 2007
    Publication date: December 27, 2007
    Inventors: Robert Sutherland, Charles Ho Fung, Barry Biddle
  • Publication number: 20070269000
    Abstract: A method of imaging a patient's uncompressed region of interest using X-ray cone beam computed tomography or cone beam digital tomography comprises the step of introducing an effective amount of a contrast agent to the uncompressed region of interest. A system for imaging a patient's uncompressed region of interest using cone beam computed tomography (CBCT) or cone beam digital tomography (CBDT) comprises an X-ray source transmitting an X-ray to the uncompressed region of interest, an image acquisition system acquiring a plurality of two-dimensional projection images data for a CBCT or CBDT data set with at least one of the projection images acquired in 35 milliseconds or less, and a processor generating a three-dimensional computed tomography image data set resolving voxels with dimensions of 0.4 mm or less in at least two orthogonal directions.
    Type: Application
    Filed: May 18, 2006
    Publication date: November 22, 2007
    Inventors: Larry Partain, Stavros Prionas, Edward Seppi, Robert Sutherland, David Humber, Hassan Mostafavi, Felix Fernando, John Boone
  • Publication number: 20070178458
    Abstract: The present invention provides novel genes and proteins for diagnosing ovarian cancer and/or a likelihood for survival, or recurrence of disease, wherein the expresson of the genes and proteins is up-regulated or down-regulated or associated with the occurrence or recurrence of a specific cancer sub-type. The ovarian cancer-associated genes and proteins of the invention are specifically exemplified by the genes and proteins set forth in Tables 1 to 5 and the Sequence Listing.
    Type: Application
    Filed: September 5, 2003
    Publication date: August 2, 2007
    Inventors: Philippa O'Brien, Robert Sutherland, Susan Henshall
  • Publication number: 20070099197
    Abstract: The present invention applies classical survival analysis to genome-wide gene expression profiles of prostate cancers and preoperative prostate-specific antigen levels from prostate cancer patient, to identify prognostic markers of disease relapse that provide additional predictive value relative to prostate-specific antigen concentration. The present invention provides a method of determining prognosis of prostate cancer and predicting prostate cancer outcome of a patient. The method comprises the steps of first establishing the threshold value of at least one prognostic gene of prostate cancer. Then, the amount of the prognostic gene from a prostate tissue of a prostate cancer patient is determined. The amount of the prognostic gene present in that patient is compared with the established threshold value of the prognostic gene, whereby the prognostic outcome of the patient is determined.
    Type: Application
    Filed: February 28, 2006
    Publication date: May 3, 2007
    Inventors: Daniel Afar, Susan Henshall, Jordan Hiller, David Mack, Robert Sutherland